BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10855826)

  • 1. Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):75-9. PubMed ID: 10855826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of rafoxanide and closantel in ovine plasma by high performance liquid chromatography.
    Benchaoui HA; McKellar QA
    Biomed Chromatogr; 1993; 7(4):181-3. PubMed ID: 8219694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability and partitioning of closantel and rafoxanide in ruminal fluid of sheep.
    Swan GE; Oliver DW; Van Rensburg J; Steyn HS; Mülders MS
    Onderstepoort J Vet Res; 2000 Jun; 67(2):97-103. PubMed ID: 11028745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetic disposition of closantel in sheep and goats.
    Hennessy DR; Sangster NC; Steel JW; Collins GH
    J Vet Pharmacol Ther; 1993 Sep; 16(3):254-60. PubMed ID: 8230396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep.
    Swan GE; Koeleman HA; Steyn HS; Mülders MS
    J S Afr Vet Assoc; 1999 Jun; 70(2):71-4. PubMed ID: 10855825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacodynamics of the flukicidal salicylanilides, rafoxanide, closantel and oxyclosanide.
    Mohammed-Ali NA; Bogan JA
    J Vet Pharmacol Ther; 1987 Jun; 10(2):127-33. PubMed ID: 3612940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of halogenated salicylanilides and their anthelmintic use in animals.
    Swan GE
    J S Afr Vet Assoc; 1999 Jun; 70(2):61-70. PubMed ID: 10855824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism and fate of closantel (Flukiver) in sheep and cattle.
    Michiels M; Meuldermans W; Heykants J
    Drug Metab Rev; 1987; 18(2-3):235-51. PubMed ID: 3330516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of a novel closantel/ivermectin injection in cattle.
    Cromie L; Ferry M; Couper A; Fields C; Taylor SM
    J Vet Pharmacol Ther; 2006 Jun; 29(3):205-11. PubMed ID: 16669865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of feed intake level on the pharmacokinetic disposition of closantel in sheep.
    Hennessy DR; Ali DN
    Int J Parasitol; 1997 Sep; 27(9):1081-6. PubMed ID: 9363491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of rafoxanide in suckling and weaned lambs following oral administration.
    Swan GE; Mülders MS
    J S Afr Vet Assoc; 1993 Jun; 64(2):67-70. PubMed ID: 8410945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep.
    El-Banna HA; Goudah A; El-Zorba H; Abd-El-Rahman S
    Parasitol Res; 2008 May; 102(6):1337-42. PubMed ID: 18297309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of closantel and rafoxanide in animal tissues by online anionic mixed-mode solid-phase extraction followed by isotope dilution liquid chromatography tandem mass spectrometry.
    Lai SS; Yeung HS; Lee WO; Ho C; Wong YT
    J Sep Sci; 2011 Jun; 34(12):1366-74. PubMed ID: 21560244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the oral bioavailability of three rafoxanide formulations in sheep.
    Swan GE; Botha CJ; Taylor JH; Mülders MS; Minnaar PP; Kloeck A
    J S Afr Vet Assoc; 1995 Dec; 66(4):197-201. PubMed ID: 8691406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of closantel and rafoxanide in bovine and ovine muscles by high-performance liquid chromatography with fluorescence detection.
    Yeung HS; Ching WH; Lai SS; Lee WO; Wong YT
    J AOAC Int; 2010; 93(5):1672-7. PubMed ID: 21140680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated pharmacological assessment of flubendazole potential for use in sheep: disposition kinetics, liver metabolism and parasite diffusion ability.
    Moreno L; Alvarez L; Mottier L; Virkel G; Bruni SS; Lanusse C
    J Vet Pharmacol Ther; 2004 Oct; 27(5):299-308. PubMed ID: 15500567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
    Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
    Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative determination of Closantel residues in milk by high-performance liquid chromatography with fluorescence detection.
    Stoev G; Dakova T; Michailova A
    J Chromatogr A; 1999 Jun; 846(1-2):383-6. PubMed ID: 10420619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of closantel and rafoxanide in animal muscles by HPLC with fluorescence detection and confirmation using MS.
    Yeung HS; Lee WO; Wong YT
    J Sep Sci; 2010 Feb; 33(2):206-11. PubMed ID: 19998374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the main route of drug entry in adult Fasciola hepatica: Further insights into closantel pharmacological activity.
    Ceballos L; Canton C; Cadenazzi G; Larsen K; Virkel G; Moreno L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2017 Oct; 181():23-29. PubMed ID: 28734749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.